Chad Cowan

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Douglas Carr, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chad Cowan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Century Therapeutics, Inc. Chief Scientific Officer Common Stock 1,178,476 $1,116,252 $0.9472 02 Feb 2026 Direct
Century Therapeutics, Inc. Chief Scientific Officer Common Stock 10,697 $10,132 $0.9472 02 Feb 2026 By Trust
Century Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 265,000 02 Feb 2026 Direct

Insider Reports Filed by Chad Cowan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IPSC Century Therapeutics, Inc. 02 Feb 2026 2 $0 4 Chief Scientific Officer 04 Feb 2026, 16:15
IPSC Century Therapeutics, Inc. 02 Jan 2026 1 -$1,603 4 Chief Scientific Officer 06 Jan 2026, 16:10
IPSC Century Therapeutics, Inc. 22 Dec 2025 1 +$49,252 4 Chief Scientific Officer 29 Dec 2025, 16:52
IPSC Century Therapeutics, Inc. 20 Nov 2025 1 -$2,736 4 Chief Scientific Officer 24 Nov 2025, 16:05
IPSC Century Therapeutics, Inc. 18 Sep 2025 1 $0 4 Chief Scientific Officer 22 Sep 2025, 16:56
IPSC Century Therapeutics, Inc. 11 Mar 2025 2 $0 4 Chief Scientific Officer 12 Mar 2025, 19:31
IPSC Century Therapeutics, Inc. 01 Oct 2024 2 $0 4 Chief Scientific Officer 03 Oct 2024, 18:04
IPSC Century Therapeutics, Inc. 01 Oct 2024 0 $0 3 Chief Scientific Officer 03 Oct 2024, 18:04